Morphisec
Company

Last deal

$31M

Amount

Series C

Stage

25.03.2021

Date

3

all rounds

$50M

Total amount

General

About Company
Morphisec provides a proactive security solution that prevents cyberattacks.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2014

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Morphisec's software uses Moving Target Defense to create a zero-trust execution environment that neutralizes attacks at the moment they happen. It exploits threat tactics like deception, modification, and polymorphism to conceal vulnerabilities in applications, web browsers, and operating systems, turning endpoints into a line of defense. This complete endpoint security solution is operationally simple, highly effective, and cost-efficient, and easily deploys into a company's existing security infrastructure. Morphisec protects over 8.5 million endpoints worldwide from ransomware, zero-day and fileless attacks, and other evasive threats at companies such as Motorola, Maersk, Citizens Medical Center, and Yaskawa.
Contacts